GlobeNewswire by notified

Siili Solutions Plc: Resolutions of the Annual General Meeting and Board of Directors

Share

Siili Solutions Plc: Resolutions of the Annual General Meeting and Board of Directors 

Siili Solutions Plc Stock Exchange Release 3 April 2024 at 4:30 p.m. EEST 

Siili Solutions Plc’s Annual General Meeting of shareholders was held today 3 April 2024 starting at 2 p.m. EEST at the address Töölönlahdenkatu 2, Helsinki, Finland in event venue Eliel, Sanomatalo.

Adoption of the financial statements and discharge from liability 

The General Meeting adopted the financial statements for the financial period 2023 including the consolidated financial statements and discharged the members of the Board of Directors and the CEO from liability for the financial period 2023.

Dividend

The General Meeting resolved that, based on the adopted balance sheet for the financial period 2023, a dividend of EUR 0.26 per share will be paid from the Company’s distributable funds, i.e., approximately EUR 2,1 million in total, and that the rest of the distributable funds be retained in equity.

The dividend will be paid to shareholders who on the dividend record date 5 April 2024 are registered in the Company’s shareholders’ register held by Euroclear Finland Oy. In accordance with the proposal, the dividend will be paid on 12 April 2024.

Remuneration report and remuneration policy

The General Meeting adopted the remuneration report and the remuneration policy of the governing bodies. The decisions of the General Meeting were of advisory nature.

Board composition, remuneration of the Board of Directors, auditor and remuneration of the auditor

It was confirmed that the number of members of the Board of Directors is five (5). The General Meeting resolved, in accordance with the proposal of the Shareholders’ Nomination Board, to re-elect the current members of the Board of Directors Harry Brade, Jesse Maula and Tero Ojanperä, for the next term of office and to elect Henna Mäkinen and Katarina Cantell as new members to the Board of Directors. 

In accordance with the Shareholders’ Nomination Board, the General Meeting resolved to renumerate the Board members as follows: The Chair of the Board is paid EUR 3,850 per month, the Deputy Chair EUR 2,500 per month and the Chair of the Audit Committee EUR 2,500 per month and other members EUR 2,000 per month. The Chairs of the Board of Directors’ Committees are paid EUR 200 per month for their work on the Committee, in addition to which all Committee members are paid a meeting fee of EUR 300 per meeting. In addition, the members of the Board of Directors receive compensation for travel expenses in line with the Company’s travel policy.

Audit firm KPMG Oy Ab was re-elected as the Company’s auditor for the following term of office. APA, Leenakaisa Winberg will continue as the responsible auditor stated by KPMG Oy Ab. KPMG Oy Ab will also carry out the assurance of the Company’s sustainability reporting. Authorised sustainability auditor (ASA) Leenakaisa Winberg will act as the responsible sustainability auditor.

In accordance with the proposal of the Board of Directors, the General Meeting resolved that the auditor of the Company be paid remuneration in accordance with the auditor’s reasonable invoice.

Board authorisations

The General Meeting authorised the Board of Directors to resolve on the repurchase and/or acceptance as pledge of the Company’s own shares under the following terms: 

A maximum of 813,800 shares may be repurchased and/or accepted as pledge, which corresponds to approximately 10% of all shares in the Company. The shares will be repurchased in trading on Nasdaq Helsinki Oy’s regulated market at a price formed in public trading on the date of repurchase. The Company’s own shares shall be repurchased to be used for carrying out acquisitions or implementing other arrangements related to the Company’s business, for optimising the Company’s capital structure, for implementing the Company’s incentive scheme or otherwise to be transferred further or cancelled.

Own shares can be repurchased otherwise than in proportion to the shareholdings of the shareholders (directed repurchase). The share purchase will decrease the Company’s distributable unrestricted equity. The Board of Directors resolves on all other terms and conditions for the repurchase and/or acceptance as pledge of the Company’s own shares.

The authorisation remains in force until the end of the next Annual General Meeting, however no later than until 30 June 2025. The authorisation revokes earlier unused authorisations to resolve on the repurchase and/or acceptance as pledge of the Company’s own shares.

Further, the General Meeting authorised the Board of Directors to resolve on the issuance of shares and the issuance of special rights entitling to shares within the meaning of chapter 10, section 1 of the Finnish Limited Liability Companies Act in one or more tranches either against consideration or free of consideration. 

The number of shares to be issued, including shares received on the basis of the special rights shall not exceed a maximum of 813,800 shares, which corresponds to approximately 10% of all shares in the Company. The Board of Directors may resolve either to issue new shares or to transfer treasury shares held by the Company.

The authorisation entitles the Board of Directors to resolve on all terms of the share issue and the issuance of special rights entitling to shares, including the right to deviate from the shareholders’ pre-emptive subscription right (directed issue). The authorisation may be used to strengthen the Company’s balance sheet and financial position, to pay purchase prices for acquisitions, in share-based incentive schemes or for other purposes resolved by the Board of Directors.

The authorisation remains in force until the end of the next Annual General Meeting, however no later than until 30 June 2025. The authorisation revokes earlier authorisations concerning share issues and the issuance other special rights entitling to shares.

Constitutive meeting of the Board of Directors

In its constitutive meeting held after the General Meeting, the Board of Directors elected Harry Brade as its Chair and Jesse Maula as its Vice Chair.

The Board of Directors also appointed the members to its committees. Henna Mäkinen, Jesse Maula and Katarina Cantell were elected to the Audit Committee. Henna Mäkinen was elected as the Chair of the Audit Committee. Harry Brade, Jesse Maula, Katarina Cantell and Tero Ojanperä were elected as the members of the HR committee. Harry Brade was elected as the Chair of the HR Committee.

All members elected to the Board of Directors are by the Board of Directors considered independent of the Company. All members of the Board of Directors, apart from Harry Brade, are considered independent of the significant shareholders of the Company. Harry Brade is the CEO of the Company’s significant shareholder Lamy Oy.

SIILI SOLUTIONS PLC

BOARD OF DIRECTORS

Further information:

Taru Kovanen, General Counsel
Phone: +358 (0)40 4176 221
Email: taru.kovanen(at)siili.com

Siili Solutions in brief: 

Siili Solutions Plc is a unique combination of a digital agency and a technology powerhouse. We believe in human-centricity in everything we deliver. Siili is the go-to partner for clients seeking growth, efficiency and competitive advantage through digital transformation. Siili has offices in Finland, Germany, Poland, Hungary, the Netherlands, Austria, the United Kingdom and USA. Siili Solutions Plc shares are listed on Nasdaq Helsinki Ltd. Siili has grown profitably since it was founded in 2005. www.siili.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

CNH NAMES GERRIT MARX AS CEO: Mr. Marx returns to CNH from Iveco Group, succeeding Scott W. Wine who has decided to leave the Company having successfully overseen the delivery of the 2021 Business Plan21.4.2024 18:21:00 CEST | Press release

CNH NAMES GERRIT MARX AS CEO Mr. Marx returns to CNH from Iveco Group, succeeding Scott W. Wine who has decided to leave the Company having successfully overseen the delivery of the 2021 Business Plan Basildon, April 21, 2024 CNH Industrial N.V. (NYSE:CNHI) announces the appointment of Gerrit Marx to the role of CEO effective July 1, 2024. He succeeds Scott Wine, whose request to leave the Company at the end of the current three-year business plan cycle to pursue other interests, has been accepted by the Board. Mr. Marx rejoins CNH from Iveco Group where as CEO he has led that company’s drive into a new era of connectivity, integrating the latest digital and data technologies with Iveco’s product offering. He has also chaired Iveco’s powertrain business overseeing its transition to alternative propulsion systems. Prior to first joining CNH in January 2019, Mr. Marx worked for 20 years in senior roles at McKinsey, Daimler Trucks, and Bain Capital, living in Brazil, China, Europe and Jap

Olof Persson to replace Gerrit Marx as CEO of Iveco Group starting from July 202421.4.2024 18:15:00 CEST | Press release

Turin, 21st April 2024. The Board of Iveco Group N.V. (EXM: IVG) (or “the Group”) announces that Olof Persson will succeed Gerrit Marx as Group CEO when the latter leaves the Group to take up his appointment as the CEO of CNH Industrial N.V. (NYSE: CNHI) on 1st July 2024. Mr. Persson, who is currently an Iveco Group Board Independent Director, will step in to the role of CEO, having been closely involved in the development of the Group’s plans as presented at our recent Capital Markets Day. Suzanne Heywood, Chair of Iveco Group commented: “On behalf of everyone at Iveco Group I’d like to thank Gerrit for his energetic and successful leadership over the past two and half years and wish him every success in his new role. We are fortunate indeed that Olof, with his wealth of relevant industry experience, will step in as CEO and provide a guarantee of continuity in execution of the plans we presented in March.” Olof Persson said: “As a Board member I have been greatly impressed by the enti

Conferize A/S offentliggør aktieemission med fortegningsret for eksisterende aktionærer21.4.2024 17:48:46 CEST | pressemeddelelse

Selskabsmeddelelse nr. 11/2024 København, den 21. april 2024 IKKE TIL OFFENTLIGGØRELSE I USA, CANADA, AUSTRALIEN, JAPAN ELLER NOGEN ANDEN JURISDIKTION, HVOR FREMSÆTTELSE AF UDBUDDET VILLE UDGØRE EN OVERTRÆDELSE AF LOVGIVNINGEN I DEN PÅGÆLDENDE JURISDIKTION. Conferize A/S offentliggør aktieemission med fortegningsret for eksisterende aktionærer Bestyrelsen i Conferize A/S („Conferize“ eller „Selskabet“) har i dag besluttet at forhøje Selskabets aktiekapital med minimum nominelt DKK 2.000.000,00 og op til nominelt DKK 5.878.705,65 fordelt på minimum 200.000.000 stk. og op til 587.870.565 stk. nye aktier a nominelt DKK 0,01 („Udbudte Aktier“) med en tegningskurs på DKK 0,01 pr. Udbudt Aktie („Tegningskursen“) med fortegningsret for Selskabets eksisterende aktionærer i forholdet 1:3 („Udbuddet“). Brutto provenuet ved en fuldtegnet emission forventes at udgøre DKK 5,9 mio. Minimum udbuddet på DKK 2,0 mio. er garanteret gennem forhånds- og garantitilsagn. Selskabet har modtaget bindende forh

Correction to Company announcement – No. 23 / 202419.4.2024 22:20:51 CEST | Press release

Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has a correction to company announcement No. 23 /2024, April 19, 2024 - regarding transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons it was reported that member of the management, Henriette Wennicke, was allocated a total of 8,008 restricted stock units with a total value of DKK 9,577,568.00. The correct number was a total of 8,008 restricted stock units with a total value of DKK 4,788,784.00. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10

Nokia Corporation: Repurchase of own shares on 19.04.202419.4.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 19 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 19.04.2024 Espoo, Finland – On 19 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL430,8933.30CEUX--BATE--AQEU--TQEX--Total430,8933.30 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

HiddenA line styled icon from Orion Icon Library.Eye